ADVFN ADVFN

Hot Features

Icon for alerts 登録してリアルタイムのアラート、カスタムポートフォリオ、市場の動きを入手してください。
6.50
0.30
(4.84%)
終了 6月13日 12:30AM

Shield Therapeutics Plc (STX) 銘柄情報

リアルタイムのディスカッションと取引のアイデア: 当社の強力なプラットフォームで自信を持って取引できます。

プレミアム

主要統計と詳細

通貨
6.50
( 4.84% )
買値
6.30
売値
6.70
出来高
2,933,979
6.20 日の範囲 6.60
2.40 52 週間の範囲 12.45
時価総額
前日終値
6.20
始値
6.20
最終取引時間
財務取引量
-
VWAP
-
平均取引量 (3 か月)
2,545,448p
発行済株式数
1,068,418,471
配当利回り
PER
-4.11
1 株当たり利益 (EPS)
-0.02
歳入
49.7M
純利益
-17.66M

Shield Therapeutics Plc について

Shield Therapeutics plc, a commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Feraccru, a non-salt based oral therapy for adults to treat the iron deficiency with... Shield Therapeutics plc, a commercial stage specialty pharmaceutical company, focuses on development and commercialization of clinical-stage pharmaceuticals to treat unmet medical needs. Its lead product is Accrufer/Feraccru, a non-salt based oral therapy for adults to treat the iron deficiency with or without anemia. Shield Therapeutics plc was incorporated in 2008 and is based in Gateshead, the United Kingdom. 詳細を表示

セクター
Healthcare
業界
Pharmaceuticals
ウェブサイト
本社
Gateshead, United Kingdom
設立
2026
Shield Therapeutics Plc is listed in the Healthcare sector of the ロンドン証券取引所 with ticker STX. The last closing price for Shield Therapeutics was 6.20p. Over the last year, Shield Therapeutics shares have traded in a share price range of 2.40p to 12.45p.

Shield Therapeutics currently has 1,068,418,471 shares in issue. The market capitalisation of Shield Therapeutics is £69.45 million. Shield Therapeutics has a price to earnings ratio (PE ratio) of -4.11.

STX 最新ニュース

期間 †前日比前日比 %始値高値安値平均出来高VWAP
10.712.06896551725.86.65.817226766.07911751DE
4-0.35-5.109489051096.856.855.7520361846.15827573DE
12-1.2-15.58441558447.79.555.7524340317.48376699DE
26-3.75-36.585365853710.2512.255.7521630828.75545495DE
523.975157.4257425742.52512.452.428485297.8654828DE
156-0.25-3.70370370376.7512.751.07531445115.1945543DE
260-50.5-88.596491228157601.07523753287.03141122DE

STX - Frequently Asked Questions (FAQ)

What is the current Shield Therapeutics Plc share price?
The current share price of Shield Therapeutics Plc is 6.50p
How many Shield Therapeutics Plc shares are in issue?
Shield Therapeutics Plc has 1,068,418,471 shares in issue
What is the market cap of Shield Therapeutics Plc?
The market capitalisation of Shield Therapeutics Plc is GBP 69.45M
What is the 1 year trading range for Shield Therapeutics Plc share price?
Shield Therapeutics Plc has traded in the range of 2.40p to 12.45p during the past year
What is the PE ratio of Shield Therapeutics Plc?
The price to earnings ratio of Shield Therapeutics Plc is -4.11
What is the cash to sales ratio of Shield Therapeutics Plc?
The cash to sales ratio of Shield Therapeutics Plc is 1.77
What is the registered address of Shield Therapeutics Plc?
The registered address for Shield Therapeutics Plc is Northern Design Centre, Gateshead, Tyne and Wear, NE8 3DF
What is the Shield Therapeutics Plc website address?
The website address for Shield Therapeutics Plc is www.shieldtherapeutics.com
Which industry sector does Shield Therapeutics Plc operate in?
Shield Therapeutics Plc operates in the Pharmaceuticals sector

STX 取引

さらに

取引は遅延しています

リアルタイムの取引を取得するには、アカウントをアップグレードしてください

リアルタイムにアップグレード

最近閲覧した銘柄

Delayed Upgrade Clock